Flat ₹100 OFF on First app order | Use Code: APP100 |
Flat ₹100 OFF
on First app order
Use Code
APP100
Download Now
100% Same
Salt CompositionEffectivenessStrength
Top Branded
Substitute
Salt Composition in bothYou Searched
Urilact 40mg Tablet ER
Anthus Pharmaceuticals Pvt. Ltd.
₹93.4
Our Recommendation
Fexanto ER 40mg Tablet 10s
522+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Treatment of Gout
Customers also bought
More About Urilact
Benefits
In Treatment of Gout Urilact 40mg Tablet ER is used to prevent and treat gout. Gout is caused by too much uric acid in your body. When the level becomes too high, crystals may form in and around certain joints and your kidneys. This can cause sudden and severe pain, redness, warmth, and swelling. This medicine works by preventing crystals from forming and reducing the levels of uric acid in your blood. This makes it less likely that you will suffer the symptoms and make them milder if you do have them. It is usually for long-term treatment and should be taken regularly until the dose is completed.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Urilact 40mg Tablet ER can be taken it with or without food, although it's advisable to take it consistently at the same time.
How it works
Urilact 40mg Tablet ER is a xanthine oxidase inhibitor. It works by decreasing blood uric acid, which is the chemical that causes gout.
Caution: It is important to consult your doctor regarding alcohol consumption while taking Urilact 40mg Tablet ER .
Seek medical advice from your doctor: Urilact 40mg Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Seek medical advice from your doctor: Urilact 40mg Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Not Safe: Urilact 40mg Tablet ER may cause side effects which could affect your ability to drive. Urilact 40mg Tablet ER may cause dizziness, sleepiness, blurred vision, numbness or tingling sensation. This may affect your driving ability.
Caution Advised: Urilact 40mg Tablet ER should be used with caution in patients with severe kidney disease. Dose adjustment of Urilact 40mg Tablet ER may be needed. Doctor consultation is advised. Limited information is available regarding the use of Urilact 40mg Tablet ER in these patients.
Caution Advised: Urilact 40mg Tablet ER should be used with caution in patients with severe liver disease. Dose adjustment of Urilact 40mg Tablet ER may be needed. Doctor consultation is advised. Limited information is available regarding the use of Urilact 40mg Tablet ER in these patients.
What if I forget to take it?
If a dose of Urilact 40mg Tablet ER is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
Anthus Pharamaceuticals Pvt. Ltd., 190 A, Pettukola Towers, P. H. Road, Kilpauk, Chennai - 600 010
References
Grosser T, Smyth E, FitzGerald GA. Anti-Inflammatory, Antipyretic, and Analgesic Agents; Pharmacotherapy of Gout. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 997-98
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 534-35
Medscape. Febuxostat (02 Apr. 2019)
Febuxostat. Wooburn Green, Buckinghamshire: A. Menarini Farmaceutica Internazionale SRL; 2008 (25 Jan. 2019)
Febuxostat. Deerfield, Illinois: Takeda Pharmaceuticals America, Inc.; 2009 (02 Apr. 2019)
Central Drugs Standard Control Organisation (CDSCO) (02 Apr. 2019)
Febuxostat (24 June 2023)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
